This week, Lauran Neergaard (AP) reported on a topic near and dear to our hearts: the fight to find – and fund – treatments for rare diseases. Our client, The Progeria Research Foundation, was mentioned as an example of an organization striving to find a treatment for the rare, rapid-aging disease in children, Progeria. While full of personality, children with Progeria die from heart attacks or stroke at an average age of 13, so the clock is ticking to find a way to help these children during their short lives. As Neergaard mentions, clinical trials are currently underway through a partnership with Merck and a treatment for this disease could help more than just the estimated 150 children with Progeria around the world – the protein that causes Progeria may play a role in the heart disease that affects millions of aging Americans.
We are honored to work with this exemplary organization and will continue to do our part by raising awareness of Progeria and PRF’s research journey as the organization works day and night to find a treatment for these children. To support PRF in their mission, please click here.







